Racial Disparities in Infant Drug Testing: A Research Note
Demography · 10.11.2026
DOI: 10.1215/00703370-12902176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Demography, erschienen am 10.11.2026. Verfasst von Mallory Dreyer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Paul H. O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, USA.
Abstract (Originalsprache)
Highlights Black infants were tested for drug exposure at more than twice the rate of White infants. Among those tested, both groups had similar positive rates—approximately 20%. Clinical risk factors explain only 38% of the racial disparity in testing rates. The remaining 61% may reflect differential treatment or unmeasured clinician observations. These findings raise concerns about fairness and trust in clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paul H. O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, USA.
ORCID-Profile: Mallory Dreyer, Cydney M McGuire, Jennifer M Silva, Kosali Simon, Coady Wing, Engy Ziedan
Zitieren
APA
Dreyer, M., McGuire, C. M., Silva, J. M., Simon, K., Wing, C., & Ziedan, E. (2026). Racial Disparities in Infant Drug Testing: A Research Note. Demography. https://doi.org/10.1215/00703370-12902176
Vancouver
Dreyer M, McGuire CM, Silva JM, Simon K, Wing C, Ziedan E. Racial Disparities in Infant Drug Testing: A Research Note. Demography. 2026. doi:10.1215/00703370-12902176
BibTeX
@article{Dreyer2026,
author = {Dreyer, Mallory and McGuire, Cydney M and Silva, Jennifer M and Simon, Kosali and Wing, Coady and Ziedan, Engy},
title = {Racial Disparities in Infant Drug Testing: A Research Note},
journal = {Demography},
year = {2026},
doi = {10.1215/00703370-12902176}
}
EUVIMED